DalsnaFinance Account

Neogen Corp $NEOG

Health Care

Russell 2000 Michigan

Create a scorecard

$11.98

+0.19 (+1.61%)

As of Oct 22, 2026, 9:33 PM EDT · cached

Price history

Loading chart…

Neogen Corp (NEOG) is trading up at $11.98 (+1.61%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Neogen Corp revenue & net income history (FY2017–FY2026)

RevenueNet incomeNet margin (right axis, %)

Neogen Corp annual financial statements
	FY2017May 2017	FY2018May 2018	FY2019May 2019	FY2020May 2020	FY2021May 2021	FY2022May 2022	FY2023May 2023	FY2024May 2024	FY2025May 2025	FY2026May 2026
Income statement
Revenue	$361.6M	$397.9M	$414.2M	$418.2M	$468.5M	$527.2M	$822.4M	$924.2M	$894.7M	$870.4M
Growth (year over year)	+12.5%	+10.0%	+4.1%	+1.0%	+12.0%	+12.5%	+56.0%	+12.4%	−3.2%	−2.7%
Gross profit	$168.9M	$186.3M	$191.9M	$196.3M	$215.1M	$243.0M	$406.0M	$463.9M	$421.4M	$408.5M
Gross margin	46.7%	46.8%	46.3%	46.9%	45.9%	46.1%	49.4%	50.2%	47.1%	46.9%
Operating income	$64.9M	$70.2M	$68.1M	$67.5M	$74.2M	$58.6M	$37.5M	$58.6M	−$1.06B	−$21.6M
Operating margin	18.0%	17.6%	16.4%	16.1%	15.8%	11.1%	4.6%	6.3%	−118.6%	−2.5%
Net income	$43.8M	$63.1M	$60.2M	$59.5M	$60.9M	$48.3M	−$22.9M	−$9.40M	−$1.09B	−$7.90M
Net margin	12.1%	15.9%	14.5%	14.2%	13.0%	9.2%	−2.8%	−1.0%	−122.1%	−0.9%
EPS (diluted)	$0.43	$0.60	$0.57	$0.56	$0.57	$0.45	−$0.12	−$0.04	−$5.03	−$0.04
Balance sheet
Cash and equivalents	$77.6M	$83.1M	$41.7M	$66.3M	$75.6M	$44.5M	$163.2M	$170.6M	$129.0M	$185.5M
Total assets	$528.4M	$618.0M	$695.7M	$797.2M	$920.2M	$992.9M	$4.55B	$4.55B	$3.44B	$3.35B
Total liabilities	$56.7M	$57.8M	$57.8M	$72.0M	$79.8M	$105.6M	$1.42B	$1.40B	$1.37B	$1.25B
Long-term debt	—	—	—	—	—	$0	$885.4M	$888.4M	$874.8M	$793.7M
Shareholders' equity	$471.6M	$560.2M	$637.9M	$725.2M	$840.4M	$887.4M	$3.13B	$3.14B	$2.07B	$2.09B
Cash flow
Operating cash flow	$60.3M	$69.1M	$63.8M	$85.9M	$81.1M	$68.0M	$41.0M	$35.3M	$58.2M	$83.2M
Capital expenditure	$14.6M	$20.9M	$14.7M	$24.1M	$26.7M	$24.4M	$65.8M	$111.4M	$104.6M	$51.3M
Free cash flow	$45.7M	$48.2M	$49.2M	$61.8M	$54.4M	$43.6M	−$24.7M	−$76.1M	−$46.4M	$31.9M
Share buybacks	—	—	$3.13M	—	—	—	—	—	—	—

RevenueNet incomeNet margin (right axis, %)

Neogen Corp quarterly financial statements
	Q2 FY25Nov 2024	Q3 FY25Feb 2025	Q4 FY25^†May 2025	Q1 FY26Aug 2025	Q2 FY26Nov 2025	Q3 FY26Feb 2026	Q4 FY26^†May 2026	Q1 FY27Aug 2026
Income statement
Revenue	$231.3M	$221.0M	$225.5M	$209.2M	$224.7M	$211.2M	$225.3M	$222.8M
Growth (year over year)	+0.7%	−3.4%	−4.8%	−3.6%	−2.8%	−4.4%	−0.1%	+6.5%
Gross profit	$113.3M	$110.3M	$92.8M	$95.0M	$106.7M	$99.0M	$107.8M	$105.5M
Gross margin	49.0%	49.9%	41.2%	45.4%	47.5%	46.9%	47.9%	47.4%
Operating income	−$457.5M	$5.40M	−$611.2M	−$16.1M	−$5.38M	−$3.30M	$3.18M	−$1.80M
Operating margin	−197.8%	2.4%	−271.1%	−7.7%	−2.4%	−1.6%	1.4%	−0.8%
Net income	−$456.3M	−$10.9M	−$612.2M	$36.3M	−$15.9M	−$17.0M	−$11.3M	−$11.9M
Net margin	−197.3%	−4.9%	−271.5%	17.4%	−7.1%	−8.0%	−5.0%	−5.3%
EPS (diluted)	−$2.10	−$0.05	−$2.82	$0.17	−$0.07	−$0.08	−$0.06	−$0.05
Balance sheet
Cash and equivalents	$140.2M	$127.7M	$129.0M	$138.9M	$145.3M	$159.9M	$185.5M	$172.0M
Total assets	$4.05B	$4.04B	$3.44B	$3.38B	$3.36B	$3.36B	$3.35B	$3.30B
Total liabilities	$1.39B	$1.38B	$1.37B	$1.26B	$1.26B	$1.26B	$1.25B	$1.22B
Long-term debt	$889.9M	$890.6M	$874.8M	$792.5M	$792.9M	$793.3M	$793.7M	$774.2M
Shareholders' equity	$2.67B	$2.66B	$2.07B	$2.12B	$2.10B	$2.10B	$2.09B	$2.09B
Cash flow
Operating cash flow	$40.3M	$19.5M	$16.4M	$10.8M	$19.5M	$22.7M	$30.2M	$12.9M
Capital expenditure	$17.2M	$32.9M	$16.1M	$24.0M	$11.7M	$11.6M	$4.00M	$8.20M
Free cash flow	$23.1M	−$13.4M	$300.0K	−$13.2M	$7.83M	$11.1M	$26.2M	$4.70M

From Neogen Corp's 10-K and 10-Q filings with the SEC; its fiscal year ends in May. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Neogen Corp

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues.

Source: Wikipedia — Neogen